| Literature DB >> 21116435 |
F Ivy Carroll1, Juan Pablo Cueva, James B Thomas, S Wayne Mascarella, Scott P Runyon, Hernán A Navarro.
Abstract
This report describes the discovery that 1-substituted 4-(3-hydroxyphenyl)piperazines are pure opioid receptor antagonists. Compounds in this new series include N-phenylpropyl (3S)-3-methyl-4-(3-hydroxyphenyl)piperazine and (3R)-3-methyl-4-(3-hydroxyphenyl)piperazine, both of which diaplay low nanomolar potencies at μ, δ, and κ receptors and pure antagonist properties in a [(35)S]GTPγS assay.Entities:
Year: 2010 PMID: 21116435 PMCID: PMC2992360 DOI: 10.1021/ml100126b
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345